Ishita Drugs & Industries Ltd

NSE: ISHITADR · BSE: 524400 · Pharmaceuticals & Biotechnology · 15 announcements

Share price: ₹81.99
Market cap: ₹24.52 Cr
Revenue (annual): ₹14.66 Cr
Net profit (annual): ₹0.78 Cr
P/E (TTM): 34.7×Sector 47.3×
Promoter holding: 50.04%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 3 Financial Results 3 Board Meeting Date 3 Debt & Borrowing 2 Promoter Buying 1 Management Change 1 Fund Raise 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

22 Sep 2026 15:27 IST BSE

Debt & Borrowing

Ishita Drugs & Industries Debt & Borrowing: ₹11.75 Cr

Ishita Drugs approved Rs.11.75 Crore borrowings from HDFC Bank, covering a term loan and working capital facility. This is within shareholder-approved borrowing limits from its 31st AGM.

Value: ₹11.75 Cr

Read the filing ↗

28 Apr 2026 14:39 IST BSE

Debt & Borrowing

Ishita Drugs & Industries Debt & Borrowing: ₹0.14 Cr

Ishita Drugs & Industries Ltd has disclosed that it is 'Not a Large Corporate' as of March 31, 2026, under SEBI's debt-raising framework. The company reported outstanding borrowings of ₹0.14 Crore. Consequently, it is not required to file specific disclosures for the Financial Year 2025-26.

Value: ₹0.14 Cr

Read the filing ↗